Ovarian conservation at the time of hysterectomy for benign disease.
Dandolu
Vani
V
Hernandez
Enrique
E
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007044:Hysterectomy; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000517:prevention & control; D010052:Ovariectomy / Q000009:adverse effects*; D014591:Uterine Diseases / Q000601:surgery
D050071:Bone Density Conservation Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors